Tower Research Capital (TRC)’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22K | Buy |
1,296
+645
| +99% | +$11K | ﹤0.01% | 3415 |
|
|
2025
Q4 | $12.2K | Sell |
651
-358
| -35% | -$5.4K | ﹤0.01% | 3505 |
|
|
2025
Q3 | $12.9K | Sell |
1,009
-521
| -34% | -$7.81K | ﹤0.01% | 3739 |
|
|
2025
Q2 | $25.7K | Sell |
1,530
-242
| -14% | -$3.27K | ﹤0.01% | 3529 |
|
|
2025
Q1 | $22.7K | Sell |
1,772
-735
| -29% | -$11.8K | ﹤0.01% | 2838 |
|
|
2024
Q4 | $44.2K | Buy |
2,507
+1,981
| +377% | +$37.6K | ﹤0.01% | 2629 |
|
|
2024
Q3 | $12K | Sell |
526
-2,254
| -81% | -$50.9K | ﹤0.01% | 3624 |
|
|
2024
Q2 | $63.8K | Buy |
2,780
+2,630
| +1,753% | +$81.1K | ﹤0.01% | 2910 |
|
|
2024
Q1 | $5.94K | Sell |
150
-4,141
| -97% | -$164K | ﹤0.01% | 4462 |
|
|
2023
Q4 | $170K | Buy |
4,291
+640
| +18% | +$26.8K | ﹤0.01% | 2234 |
|
|
2023
Q3 | $162K | Buy |
3,651
+3,210
| +728% | +$140K | 0.01% | 1583 |
|
|
2023
Q2 | $19.2K | Sell |
441
-908
| -67% | -$39.9K | ﹤0.01% | 3422 |
|
|
2023
Q1 | $59K | Buy |
1,349
+1,175
| +675% | +$51.9K | ﹤0.01% | 2352 |
|
|
2022
Q4 | $6K | Sell |
174
-609
| -78% | -$23.6K | ﹤0.01% | 4741 |
|
|
2022
Q3 | $32K | Buy |
783
+144
| +23% | +$5.33K | ﹤0.01% | 3552 |
|
|
2022
Q2 | $24K | Sell |
639
-234
| -27% | -$8.46K | ﹤0.01% | 3611 |
|
|
2022
Q1 | $35K | Buy |
873
+185
| +27% | +$7.24K | ﹤0.01% | 3010 |
|
|
2021
Q4 | $29K | Buy |
688
+53
| +8% | +$2.3K | ﹤0.01% | 3265 |
|
|
2021
Q3 | $27K | Sell |
635
-59
| -9% | -$2.97K | ﹤0.01% | 3459 |
|
|
2021
Q2 | $32K | Sell |
694
-642
| -48% | -$30.5K | ﹤0.01% | 3427 |
|
|
2021
Q1 | $62K | Sell |
1,336
-3,011
| -69% | -$146K | ﹤0.01% | 2941 |
|
|
2020
Q4 | $186K | Sell |
4,347
-9,921
| -70% | -$509K | 0.01% | 1766 |
|
|
2020
Q3 | $702K | Buy |
14,268
+11,606
| +436% | +$642K | 0.01% | 1316 |
|
|
2020
Q2 | $155K | Buy |
+2,662
| New | +$141K | 0.01% | 2034 |
|
|
2019
Q4 | – | Sell |
-376
| Closed | -$22K | – | 4115 |
|
|
2019
Q3 | $22K | Buy |
376
+215
| +134% | +$13.3K | ﹤0.01% | 2416 |
|
|
2019
Q2 | $9K | Sell |
161
-24
| -13% | -$1.11K | ﹤0.01% | 2620 |
|
|
2019
Q1 | $7K | Sell |
185
-475
| -72% | -$18.6K | ﹤0.01% | 2879 |
|
|
2018
Q4 | $25K | Buy |
660
+435
| +193% | +$16.7K | ﹤0.01% | 1769 |
|
|
2018
Q3 | $9K | Sell |
225
-741
| -77% | -$28.1K | ﹤0.01% | 2828 |
|
|
2018
Q2 | $36K | Buy |
+966
| New | +$33.7K | ﹤0.01% | 2056 |
|
|
2017
Q4 | – | Sell |
-1,590
| Closed | -$60K | – | 3841 |
|
|
2017
Q3 | $60K | Buy |
1,590
+1,469
| +1,214% | +$46.1K | 0.01% | 1807 |
|
|
2017
Q2 | $3K | Sell |
121
-1,604
| -93% | -$39.2K | ﹤0.01% | 2223 |
|
|
2017
Q1 | $34K | Buy |
1,725
+1,639
| +1,906% | +$30.3K | ﹤0.01% | 947 |
|
|
2016
Q4 | $2K | Buy |
+86
| New | +$1.42K | ﹤0.01% | 3439 |
|
|
2016
Q3 | – | Sell |
-1,049
| Closed | -$14K | – | 4177 |
|
|
2016
Q2 | $14K | Buy |
+1,049
| New | +$14.8K | ﹤0.01% | 2536 |
|
|
2016
Q1 | – | Sell |
-2,390
| Closed | -$39K | – | 4671 |
|
|
2015
Q4 | $39K | Buy |
2,390
+2,025
| +555% | +$30.8K | 0.01% | 713 |
|
|
2015
Q3 | $4K | Sell |
365
-35
| -9% | -$465 | ﹤0.01% | 2955 |
|
|
2015
Q2 | $6K | Buy |
400
+92
| +30% | +$1.3K | ﹤0.01% | 3126 |
|
|
2015
Q1 | $4K | Buy |
+308
| New | +$4.35K | ﹤0.01% | 3410 |
|
|
2014
Q4 | – | Sell |
-5,923
| Closed | -$77K | – | 4468 |
|
|
2014
Q3 | $77K | Buy |
5,923
+3,665
| +162% | +$50.4K | 0.01% | 1178 |
|
|
2014
Q2 | $32K | Sell |
2,258
-956
| -30% | -$14.4K | ﹤0.01% | 1561 |
|
|
2014
Q1 | $53K | Buy |
+3,214
| New | +$53.8K | 0.01% | 1051 |
|
Other funds holding NRC
VCM
QI
Tower Research Capital (TRC)'s NRC Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its NRC Health Common Stock (NRC) stake by 99% in Q1 2026, buying an estimated $11K and bringing the position to 1,296 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.
Tower Research Capital (TRC) first reported a position in NRC in Q1 2014 and has held it in 42 quarters since. The position peaked at $702K in Q3 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Tower Research Capital (TRC) held 1,296 shares of NRC Health Common Stock worth $22K as of Q1 2026.
- Tower Research Capital (TRC) bought 645 NRC Health Common Stock shares in Q1 2026, an estimated $11K.
- NRC Health Common Stock made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3415 holding.
- Tower Research Capital (TRC) first reported a position in NRC Health Common Stock in Q1 2014 and has held it in 42 quarters since.
- Tower Research Capital (TRC)'s NRC Health Common Stock position peaked at $702K in Q3 2020.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.